Gentiva Health Sciences’ shares gain after the company, which has rejected Kindred Healthcare’s buyout bids, provided a second-quarter earnings outlook that was above analyst expectations.
read more
Gentiva Health Sciences’ shares gain after the company, which has rejected Kindred Healthcare’s buyout bids, provided a second-quarter earnings outlook that was above analyst expectations.
read more